Cannabix Technologies Receives NHTSA Approval for BreathLogix Workplace Series Alcohol Breathalyzer
Cannabix Technologies (BLOZF) has received NHTSA approval for its BreathLogix Workplace Series alcohol breathalyzer. The device has met the USDOT model specifications for breath alcohol screening devices and will be added to the U.S. Federal Register Conforming Products List. The BreathLogix WS features rapid breath alcohol checking, simultaneous user photo capture, and real-time manager alerts.
Key features include precise BAC level detection, SMS/email test reports, integration capabilities with various access control systems, and patent-pending pre-calibrated sensor cartridge technology. The device is designed for multiple applications including construction, transportation, healthcare, manufacturing, and other safety-sensitive industries.
Cannabix Technologies (BLOZF) ha ottenuto l'approvazione della NHTSA per il suo alcoltest BreathLogix Workplace Series. Il dispositivo soddisfa le specifiche del modello USDOT per i dispositivi di rilevamento dell'alcol nel respiro e sarà inserito nella Conforming Products List del Registro Federale degli Stati Uniti. Il BreathLogix WS offre un controllo rapido del tasso alcolemico nel respiro, la cattura simultanea della foto dell'utente e avvisi in tempo reale per i responsabili.
Le caratteristiche principali includono una rilevazione precisa del livello di BAC, report dei test via SMS/email, capacità di integrazione con diversi sistemi di controllo accessi e una tecnologia brevettata in attesa di brevetto per la cartuccia sensore pre-calibrata. Il dispositivo è progettato per molteplici applicazioni, tra cui edilizia, trasporti, sanità, manifattura e altri settori sensibili alla sicurezza.
Cannabix Technologies (BLOZF) ha recibido la aprobación de la NHTSA para su alcoholímetro BreathLogix Workplace Series. El dispositivo cumple con las especificaciones del modelo USDOT para dispositivos de detección de alcohol en el aliento y será añadido a la Lista de Productos Conformes del Registro Federal de EE.UU. El BreathLogix WS cuenta con una comprobación rápida del alcohol en el aliento, captura simultánea de la foto del usuario y alertas en tiempo real para los gerentes.
Las características clave incluyen una detección precisa del nivel de BAC, informes de pruebas por SMS/correo electrónico, capacidades de integración con varios sistemas de control de acceso y tecnología de cartucho sensor pre-calibrado pendiente de patente. El dispositivo está diseñado para múltiples aplicaciones, incluyendo construcción, transporte, salud, manufactura y otras industrias sensibles a la seguridad.
Cannabix Technologies (BLOZF)가 BreathLogix Workplace Series 알코올 측정기에 대해 NHTSA 승인을 받았습니다. 이 장치는 USDOT 호흡 알코올 측정기 모델 사양을 충족하였으며 미국 연방 등록부의 적합 제품 목록에 추가될 예정입니다. BreathLogix WS는 빠른 호흡 알코올 검사, 사용자 사진 동시 촬영, 실시간 관리자 경고 기능을 제공합니다.
주요 기능으로는 정확한 BAC 수준 감지, SMS/이메일 테스트 보고서, 다양한 출입 통제 시스템과의 통합 기능, 특허 출원 중인 사전 교정된 센서 카트리지 기술이 포함됩니다. 이 장치는 건설, 운송, 의료, 제조 및 기타 안전 민감 산업 등 다양한 분야에 적합하게 설계되었습니다.
Cannabix Technologies (BLOZF) a obtenu l'approbation de la NHTSA pour son éthylotest BreathLogix Workplace Series. L'appareil répond aux spécifications du modèle USDOT pour les dispositifs de dépistage de l'alcool dans l'haleine et sera ajouté à la liste des produits conformes du registre fédéral américain. Le BreathLogix WS propose un contrôle rapide de l'alcoolémie dans l'haleine, la capture simultanée de la photo de l'utilisateur et des alertes en temps réel pour les responsables.
Les principales caractéristiques incluent une détection précise du niveau d'alcoolémie, des rapports de test par SMS/email, des capacités d'intégration avec divers systèmes de contrôle d'accès, ainsi qu'une technologie de cartouche de capteur pré-calibrée en instance de brevet. L'appareil est conçu pour de multiples applications, notamment dans la construction, le transport, la santé, la fabrication et d'autres industries sensibles à la sécurité.
Cannabix Technologies (BLOZF) hat die NHTSA-Zulassung für sein BreathLogix Workplace Series Alkohol-Atemgerät erhalten. Das Gerät erfüllt die USDOT-Modellspezifikationen für Atemalkoholmessgeräte und wird in die Conforming Products List des US-Bundesregisters aufgenommen. Der BreathLogix WS bietet eine schnelle Atemalkoholprüfung, gleichzeitige Benutzerfotoaufnahme und Echtzeit-Benachrichtigungen für Manager.
Zu den Hauptmerkmalen gehören präzise BAC-Wert-Erkennung, SMS-/E-Mail-Testberichte, Integrationsmöglichkeiten mit verschiedenen Zutrittskontrollsystemen sowie eine zum Patent angemeldete, vorkalibrierte Sensorkartuschentechnologie. Das Gerät ist für vielfältige Anwendungen konzipiert, darunter Bauwesen, Transport, Gesundheitswesen, Fertigung und andere sicherheitskritische Branchen.
- Received NHTSA approval for BreathLogix Workplace Series alcohol breathalyzer
- Patent-pending pre-calibrated sensor technology eliminates costly maintenance and calibration needs
- Multiple revenue streams through various industry applications
- Advanced discussions ongoing with potential distributors for sales and marketing
- None.
Cannabix has developed an autonomous alcohol breathalyzer screening device for employers and a range of industries and safety settings
VANCOUVER, British Columbia, May 05, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) reports that it has received notice from the U.S. National Highway Traffic Safety Association (NHTSA) for the approval of its BreathLogix “Workplace Series” (WS) alcohol breathalyzer. The BreathLogix WS alcohol screening device (see Figure 1) was recently evaluated by the Volpe Transportation Systems Center and determined to meet the United States Department of Transportation (USDOT) model specifications for breath alcohol screening devices (ASD). The BreathLogix WS will be added to the U.S. Federal Register Conforming Products List (CPL) for breath alcohol screen devices. The USDOT and NHTSA are the primary government entities charged with the safety of motor vehicle operation and road travel in the United States. BreathLogix rapidly checks breath alcohol, simultaneously takes a photo of the user, alerts managers in real-time to help avoid injury and damage due to alcohol impairment.
The Company is advancing discussions with potential distributors for the sales and marketing of the BreathLogix series of alcohol devices in the U.S. and elsewhere. BreathLogix is targeted for a range of applications and virtually all safety sensitive industries including, construction, transportation, healthcare, manufacturing, warehouse settings, 24/7 programs, sea vessels, docks, restaurants and airlines.
Figure 1. BreathLogix Workplace Series Alcohol Screening Device
Figure 2. BreathLogix Alcohol device available with contactless and straw modes for rapid pre-access alcohol screening
BreathLogix Alcohol Screening Devices
BreathLogix rapidly checks for breath alcohol and simultaneously takes a photo of the user to confirm and record identity. The device delivers precise Blood Alcohol Content (BAC) levels on the screen and sends real-time test reports via SMS and e-mail, alerting managers to positive BAC results so they can take immediate action to avoid damage and injury. All test results are logged and managed on a dedicated ‘Connect’ web portal. BreathLogix can be integrated with doors, turnstiles, gates, facial recognition, fingerprint readers and motor vehicle key fleet management systems for pre-access alcohol testing. Furthermore, the device can be used for start-of-shift testing, mandated testing, pre-employment testing, return-to-work testing, random and post-incident testing.
BreathLogix includes patent pending pre-calibrated sensor cartridge technology allowing administrators to easily maintain their devices and eliminate the need for costly calibration equipment and time-consuming site visits from technicians for maintenance.
About Cannabix Technologies Inc.
Cannabix Technologies Inc. is a developer of marijuana and alcohol breath technologies for workplaces, law enforcement and other settings. Breath testing for delta-9 THC (the primary psychoactive ingredient in cannabis) focuses on recent marijuana use. Cannabix is the developer of the BreathLogix autonomous alcohol screening device for organizations who strive to improve alcohol safety and monitoring.
We seek Safe Harbor.
On behalf of the Board of Directors
“Rav Mlait”
CEO
Cannabix Technologies Inc.
For further information, contact the Company at info@cannabixtechnologies.com
The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.
Cautionary Statement Regarding Forward-Looking Statements
This news release contains certain "forward-looking statements" within the meaning of such statements under applicable securities law. Forward-looking statements are frequently characterized by words such as "anticipates," "plan," "continue," "expect," "project," "intend," "believe," "anticipate," "estimate," "may," "will," "potential," "proposed," "positioned" and other similar words, or statements that certain events or conditions "may" or "will" occur. Forward-looking statements in this news release include, but are not limited to, statements relating to: certification of devices, acceptance of devices by international regulators, the achievement of any or all of the goals and aims of distributors; the completion of pre-validation or validation testing described in this news release; final development of a commercial or prototype product(s); the successful trial or pilot of company technologies; the commercialization of the Company's products; the negotiation and potential entry into additional agreements with distributors; and the completion of future financings. There are numerous risks and uncertainties that could cause actual results and the Company’s plans and objectives to differ materially from those expressed in the forward-looking information. Important factors that could cause actual results to differ materially from those expressed in the forward-looking information include (but are note limited to): adverse market conditions; risks regarding protection of proprietary technology; the ability of the Company to complete future financings; the ability of the Company to develop and market its future product; risks regarding government regulation, managing and maintaining growth, the effect of adverse publicity, litigation, competition; that the Company’s development of cannabis and alcohol breathalyzer technologies will provide any benefit to the Company; there is no assurance that any proposed new products will be built, will be successful in beta testing or clinical trials; there is no assurance that the Company will enter into any partnerships to advance any of its corporate initiatives or technologies; there is no assurance that any “patent pending” or “provisional patents” technologies licensed by the Company or owned by the Company will receive patent status by regulatory authorities; the Company is not currently selling breathalyzers and there is no assurance that the Company ever will; and other factors beyond the control of the Company. Actual results and future events could differ materially from those anticipated in such information. These and all subsequent written and oral forward-looking information are based on estimates and opinions of management on the dates they are made and are expressly qualified in their entirety by this notice. Except as required by law, the Company does not intend to update these forward-looking statements.
Photos accompanying this announcement are available at:
https://www.globenewswire.com/NewsRoom/AttachmentNg/78d7e46e-d0a8-40fd-8270-7ef850be62dc
https://www.globenewswire.com/NewsRoom/AttachmentNg/d6740a95-41ad-4841-a33d-2fc5d669508e
FAQ
What approval did Cannabix Technologies (BLOZF) receive from NHTSA in May 2025?
What are the key features of the BreathLogix Workplace Series breathalyzer?
Which industries is the BLOZF BreathLogix breathalyzer designed for?
How does the BreathLogix maintenance system work?
What integration capabilities does the BreathLogix breathalyzer offer?
